This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Survey of Residency Program Directors

Peter R. Lichstein, MD; Robert C. Turner, MD; Kevin O'Brien, PhD

Arch Intern Med. 1992;152(5):1009-1013.

Abstract
To survey internal medicine residency program directors regarding interactions between their residents and pharmaceutical company (PC) representatives (PCRs) a questionnaire was sent to the directors of all Accreditation Council for Graduate Medical Education—approved internal medicine residency programs. The survey included 444 program directors, of whom 272 (61.16%) responded. The majority of program directors, 228 (83.8%), allowed PCRs to meet with residents during working hours and 241 (88.6%) permitted PC sponsorship of conferences. About half of the program directors were "moderately" or "very" concerned about the potential adverse effects of PC marketing on resident attitudes and prescribing practices. Seventy percent "agreed" or "strongly agreed" that the benefits of PC sponsorship outweigh the adverse effects and 41.5% believed that refusal to allow PCRs to meet with residents would jeopardize PC funding of other departmental activities. Most program directors reported that alternate funds for conferences were available if PC support was withdrawn. "Unethical" marketing activities were observed by 14.3% of program directors and 37.5% reported that residents had participated in PC-sponsored trips during the 3 years prior to the survey. At the time of this survey, only 35.3% of programs had developed formal policies regulating PCR activities and 25.7% provided residents with formal instruction on marketing issues. Knowledge of the current extent of PCR interactions with residents may be helpful to program directors in developing policies regulating PCmarketing activities.

(Arch Intern Med. 1992;152:1009-1013)

Author Affiliations
From the Departments of Medicine (Drs Lichstein and Turner) and Center for Biostatistics, Division of Health Sciences (Dr O'Brien), East Carolina University, Greenville, NC.

Footnotes
Accepted for publication December 31, 1991.

Reprint requests to the Department of Medicine, East Carolina University School of Medicine, Greenville, NC 27858-4354 (Dr Lichstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?
Carroll et al.
Pediatrics 2007;120:e1528-e1535.
ABSTRACT | FULL TEXT  

Medical Education and the Pharmaceutical Industry: A Review of Ethical Guidelines and Their Implications for Psychiatric Training
Geppert
Acad. Psychiatry 2007;31:32-39.
ABSTRACT | FULL TEXT  

The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
Brodkey
Acad. Psychiatry 2005;29:222-229.
ABSTRACT | FULL TEXT  

Attitudes and Behaviors of Psychiatry Residents Toward Pharmaceutical Representatives Before and After an Educational Intervention
Randall et al.
Acad. Psychiatry 2005;29:33-39.
ABSTRACT | FULL TEXT  

A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry
Varley et al.
Acad. Psychiatry 2005;29:40-46.
ABSTRACT | FULL TEXT  

Are Gifts From Pharmaceutical Companies Ethically Problematic?: A Survey of Physicians
Brett et al.
Arch Intern Med 2003;163:2213-2218.
ABSTRACT | FULL TEXT  

Best Practices: Developing Ethical Guidelines for Pharmaceutical Company Support in an Academic Mental Health Center
Steiner et al.
Psychiatr. Serv. 2003;54:1079-1089.
ABSTRACT | FULL TEXT  

Physician-Industry Relations. Part 1: Individual Physicians
Coyle and for the Ethics and Human Rights Committee, America
ANN INTERN MED 2002;136:396-402.
ABSTRACT | FULL TEXT  

Physician-Industry Relations. Part 2: Organizational Issues
Coyle and for the Ethics and Human Rights Committee, America
ANN INTERN MED 2002;136:403-406.
ABSTRACT | FULL TEXT  

Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior
McCormick et al.
JAMA 2001;286:1994-1999.
ABSTRACT | FULL TEXT  

Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana
JAMA 2000;283:373-380.
ABSTRACT | FULL TEXT  

Interactions Between Physicians and the Health Care Technology Industry
Tenery
JAMA 2000;283:391-393.
FULL TEXT  

Pharmaceutical Companies and Academic Departments of Psychiatry: A Call for Ethics Education
Christensen and Tueth
Acad. Psychiatry 1998;22:135-137.
ABSTRACT | FULL TEXT  

The Accuracy of Drug Information From Pharmaceutical Sales Representatives
Ziegler et al.
JAMA 1995;273:1296-1298.
ABSTRACT  

Medical Residents and the Pharmaceutical Industry
Rosner
Arch Intern Med 1992;152:2507-2507.
ABSTRACT  

The Relationship Between Physicians in Training and Pharmaceutical Companies: A Time for Guidelines?
Girard
Arch Intern Med 1992;152:920-921.
ABSTRACT